Transplant Surgery · Omaha, NE
NPI
1104933878
Since 2006
Specialty
Transplant Surgery
Code 204F00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
988102 Nebraska Medical Ctr
Omaha, NE, 68198
Phone (402) 559-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
289 services
Medicare patients, 2024
86
Average age 61
Drug cost, 2024
$2.4M
863 prescriptions
Company payments, 2025
$26K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David F Mercer was code 99232 (hospital e&m - subsequent), 162 times for 34 patients. In total David F Mercer billed 289 services in 42 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 162 | 34 | $57.18 | $9,264 |
| 99213 Office E&M - Established | Facility | 36 | 24 | $42.24 | $1,521 |
By year: 2022 $48K for 307 services; 2023 $45K for 264 services; 2024 $54K for 289 services.
Medicare prescription drug claims, 2024
In 2024, the drug David F Mercer prescribed most often to Medicare patients was Sodium Chloride (0.9 % Sodium Chloride), with 194 prescriptions and refills. In total David F Mercer wrote 863 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sodium Chloride 0.9 % Sodium Chloride | 194 | 194 | 12 | $8,244 |
| Vancomycin Hcl Generic | 122 | 122 | Under 11 | $5,423 |
| Gentamicin Sulfate Gentamicin Sulfate/Pf | 78 | 78 | Under 11 | $1,476 |
| Gattex Teduglutide | 45 | 45 | Under 11 | $2.3M |
| Daptomycin Generic | 29 | 29 | Under 11 | $2,218 |
| Pantoprazole Sodium Generic | 25 | 28 | Under 11 | $194 |
| Sodium Chloride Generic | 24 | 24 | Under 11 | $2,727 |
| Potassium Chloride Generic | 20 | 20 | Under 11 | $1,615 |
| Ondansetron Odt Ondansetron | 20 | 29 | 12 | $840 |
| Famotidine Generic | 19 | 19 | Under 11 | $355 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 19 | 26 | Under 11 | $147 |
| Loperamide Loperamide Hcl | 18 | 20 | Under 11 | $526 |
| Omeprazole Generic | 16 | 26 | Under 11 | $69.4 |
| Sulfasalazine Generic | 14 | 14 | Under 11 | $184 |
| Metronidazole Generic | 14 | 14 | Under 11 | $117 |
Brand drugs: 355 claims; generic drugs: 508 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David F Mercer $26K ($26K in general payments such as food, travel and fees) from 5 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $26K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.